We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-6.62%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$159M
AUM Growth
-$13M
Cap. Flow
-$34.8K
Cap. Flow %
-0.02%
Top 10 Hldgs %
22.04%
Holding
189
New
40
Increased
46
Reduced
55
Closed
32

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$1.24M
2
ARW icon
Arrow Electronics
ARW
+$1.12M
3
IDXX icon
Idexx Laboratories
IDXX
+$918K
4
ROL icon
Rollins
ROL
+$908K
5
DHR icon
Danaher
DHR
+$906K

Top Sells

Rank Stock Value
1
LNG icon
Cheniere Energy
LNG
+$2.66M
2
WMT icon
Walmart Inc
WMT
+$2.1M
3
CHRW icon
C.H. Robinson
CHRW
+$1.39M
4
ABT icon
Abbott
ABT
+$1.31M
5
AME icon
Ametek
AME
+$1.26M

Sector Composition

Rank Sector Weight
1 Industrials 21.35%
2 Healthcare 19.44%
3 Financials 12.65%
4 Consumer Staples 12.28%
5 Technology 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
126
Boeing
BA
$166B
$316K 0.2%
2,613
INTC icon
127
Intel
INTC
$513B
$309K 0.19%
11,983
-850
-7% -$29K
GE icon
128
GE Aerospace
GE
$319B
$307K 0.19%
7,964
COST icon
129
Costco
COST
$400B
$295K 0.19%
+625
New +$325K
MA icon
130
Mastercard
MA
$502B
$294K 0.19%
1,035
-90
-8% -$29.8K
APD icon
131
Air Products & Chemicals
APD
$64.7B
$285K 0.18%
+1,225
New +$303K
CME icon
132
CME Group
CME
$98.9B
$261K 0.16%
+1,475
New +$292K
DCI icon
133
Donaldson
DCI
$10.1B
$261K 0.16%
5,325
SHW icon
134
Sherwin-Williams
SHW
$78.5B
$256K 0.16%
1,250
MPC icon
135
Marathon Petroleum
MPC
$115B
$253K 0.16%
2,543
-6,950
-73% -$651K
FLIC
136
DELISTED
First of Long Island Corp
FLIC
$252K 0.16%
14,625
-600
-4% -$11.1K
ALL icon
137
Allstate
ALL
$65B
$249K 0.16%
2,000
AAP icon
138
Advance Auto Parts
AAP
$2.62B
$242K 0.15%
+1,550
New +$283K
SCHW
139
Charles Schwab
SCHW
$186B
$241K 0.15%
+3,350
New +$233K
PPG icon
140
PPG Industries
PPG
$23.3B
$237K 0.15%
+2,145
New +$265K
MAS icon
141
Masco
MAS
$13.6B
$234K 0.15%
+5,010
New +$261K
TSN icon
142
Tyson Foods
TSN
$18.5B
$234K 0.15%
+3,550
New +$281K
INTU icon
143
Intuit
INTU
$88B
$232K 0.15%
600
+50
+9% +$21.6K
SRE icon
144
Sempra
SRE
$53.1B
$232K 0.15%
+3,100
New +$251K
K
145
DELISTED
Kellanova
K
$231K 0.15%
3,525
-107
-3% -$7.35K
XYL icon
146
Xylem
XYL
$25.1B
$227K 0.14%
2,600
NEE icon
147
NextEra Energy
NEE
$169B
$212K 0.13%
2,700
-3,040
-53% -$258K
DXCM icon
148
DexCom
DXCM
$32.6B
$209K 0.13%
+2,590
New +$219K
CMCSA icon
149
Comcast
CMCSA
$86.7B
$202K 0.13%
6,900
DRI icon
150
Darden Restaurants
DRI
$23.7B
$202K 0.13%
+1,600
New +$200K

Similar funds

New England Research & Management's Q3 2022 Portfolio in Review

As of Q3 2022, New England Research & Management held 189 positions worth $159M, down 7.6% from $172M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2022 filing shows 40 new, 46 increased, 55 reduced and 32 closed positions. Its largest new stake was United Therapeutics: 5,550 shares worth $1.16M. The largest sale was Cheniere Energy, an estimated $2.66M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2022 buy was United Therapeutics: 5,550 shares worth $1.16M.
  • New England Research & Management added most to Coca-Cola in Q3 2022, an estimated $817K increase.
  • New England Research & Management's biggest Q3 2022 reduction was Walmart Inc, cutting an estimated $2.1M.
  • New England Research & Management fully exited Cheniere Energy in Q3 2022, selling an estimated $2.66M.
  • New England Research & Management's ten largest holdings make up 22% of its $159M portfolio in Q3 2022.
  • New England Research & Management opened 40 new positions and closed 32 in Q3 2022.
  • New England Research & Management's portfolio value fell 7.6% quarter-over-quarter to $159M.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.